Cytori Therapeutics (CYTX)

0.26 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/9/18 *Est.)

Latest Headlines

Form 424B4 CYTORI THERAPEUTICS, June 25, 2018 9:02 AM - SEC Filing Cytori Therapeutics Reminds Investors of Today’s Deadline to be a Shareholder of Record June 22, 2018 12:00 PM - Globe NewsWire Form 8-K CYTORI THERAPEUTICS, For: Jun 19 June 20, 2018 9:00 AM - SEC Filing Cytori Therapeutics (CYTX) Discloses Roche is Terminating Existing Supply Agreement for Enzymes June 12, 2018 5:21 PM - StreetInsider Form 8-K CYTORI THERAPEUTICS, For: Jun 08 June 12, 2018 5:16 PM - SEC Filing Form FWP CYTORI THERAPEUTICS, Filed by: CYTORI THERAPEUTICS, INC. June 12, 2018 8:34 AM - SEC Filing Cytori Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering June 12, 2018 8:30 AM - Globe NewsWire Form 8-K CYTORI THERAPEUTICS, For: Jun 08 June 11, 2018 9:01 AM - SEC Filing Form S-1/A CYTORI THERAPEUTICS, June 6, 2018 6:52 AM - SEC Filing Form 8-K CYTORI THERAPEUTICS, For: May 31 June 1, 2018 4:36 PM - SEC Filing Form 424B5 CYTORI THERAPEUTICS, June 1, 2018 4:33 PM - SEC Filing Form SD CYTORI THERAPEUTICS, May 30, 2018 4:32 PM - SEC Filing B.Riley/FBR Remains Bullish on Cytori Therapeutics (CYTX) May 29, 2018 6:46 AM - StreetInsider Form SC 13G/A CYTORI THERAPEUTICS, Filed by: PostFinance AG May 24, 2018 4:18 PM - SEC Filing Form 8-K CYTORI THERAPEUTICS, For: May 23 May 23, 2018 5:01 PM - SEC Filing Cytori Therapeutic’s common stock to begin trading on adjusted basis on May 24, following one-for-ten reverse split May 23, 2018 4:55 PM - Globe NewsWire Form CERT CYTORI THERAPEUTICS, May 23, 2018 3:51 PM - SEC Filing Form 8-K CYTORI THERAPEUTICS, For: May 18 May 18, 2018 4:31 PM - SEC Filing Cytori Therapeutics, Inc. (CYTX) PT Lowered to $0.55 at Ascendiant Capital May 14, 2018 1:51 AM - StreetInsider Form 10-Q CYTORI THERAPEUTICS, For: Mar 31 May 11, 2018 5:04 PM - SEC Filing Form 8-K CYTORI THERAPEUTICS, For: May 10 May 10, 2018 4:54 PM - SEC Filing Cytori Therapeutics (CYTX) Misses Q1 EPS by 1c May 10, 2018 4:28 PM - StreetInsider Cytori Reports Q1 2018 Business and Financial Results May 10, 2018 4:25 PM - Globe NewsWire Cytori to Webcast First Quarter Financial Results on May 10 May 7, 2018 4:15 PM - Globe NewsWire H.C. Wainwright Starts Cytori Therapeutics, Inc. (CYTX) at Buy May 7, 2018 7:24 AM - StreetInsider Cytori Therapeutics (CYTX) Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin April 30, 2018 8:35 AM - StreetInsider Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin April 30, 2018 8:30 AM - Globe NewsWire Form S-1 CYTORI THERAPEUTICS, April 27, 2018 5:15 PM - SEC Filing Form EFFECT CYTORI THERAPEUTICS, April 11, 2018 6:02 AM - SEC Filing Form SC 13G/A CYTORI THERAPEUTICS, Filed by: PostFinance AG April 10, 2018 6:07 AM - SEC Filing Form S-3/A CYTORI THERAPEUTICS, April 6, 2018 5:08 PM - SEC Filing Form DEF 14A CYTORI THERAPEUTICS, For: May 18 April 6, 2018 4:56 PM - SEC Filing Cytori Therapeutics (CYTX) Reports Full Enrollment in ADRESU Clinical Trial of Cytori Cell Therapy for Stress Urinary Incontinence March 28, 2018 12:08 PM - StreetInsider Enrollment Completed in ADRESU Clinical Trial of Cytori Cell Therapy™ for Stress Urinary Incontinence March 28, 2018 12:00 PM - Globe NewsWire Full Article List